The global state of customer-centricity in pharma 2021


On June 10, 2021, Trilations CEO Johan Vermeiren presented to Intellus members an overview of results from our 2021 Global Pharma Customer Centricity Index, which also included Omnichannel Interaction Insights and the “new normal.” This presentation focused on US and EU5 results for immunology and oncology/hematology, with a snapshot of the same for Japan, Brazil, China and Australia.

From our analysis, we also yielded insights on the impact of being patient-centric and physician-centric on share, and the impact of harmonized and personalized engagement on being perceived as “best interaction.”
We will continue to provide you with more insights on these important topics for pharma commercial and medical affairs organizations.

If you would like insights focused on your treatment area and geography, reach out to Brad Tritle, General Manager for Trilations in the Americas.

You can view the Intellus webinar presentation below.

 

Reach out for more information

Bradley Tritle, General Manager Americas

Full recording

This presentation was given by

Johan Vermeiren

&

supported by

Bradley Tritle

Feel free to reach out to them.

Our aim is to be the preferred business partner of our customers, by providing innovative, added value services via engaged consultants.
Johan Vermeiren CEO
“We are committed to serving the North American and LATAM markets from our new US office. Our unique expertise in fact-based HCP insights, applied in various frameworks across the entire pharma and medical device life cycle, help your brand and company succeed!”
Bradley Tritle General Manager Americas
Questions about our expertise? Struggling with a specific challenge? I am at your service to help you find / talk about the best solution.
Hendrik Verplancke Sales Director

Related content

Pharma-Customer-Centricity-Index

Read more